Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection

Kerryl E. Greenwood-Quaintance; Peggy Kohner; Douglas R. Osmon; Abinash Virk; Robin Patel

doi:10.1016/j.diagmicrobio.2015.03.002

Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection

Kerryl E. Greenwood-Quaintance, Peggy Kohner, Douglas R. Osmon, Abinash Virk, Robin Patel

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC<inf>90</inf>/MIC<inf>50</inf> were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.

Original language	English (US)
Pages (from-to)	177-178
Number of pages	2
Journal	Diagnostic Microbiology and Infectious Disease
Volume	82
Issue number	2
DOIs	https://doi.org/10.1016/j.diagmicrobio.2015.03.002
State	Published - Jun 1 2015

Keywords

Ceftriaxone
Oxacillin-susceptible Staphylococcus aureus
Prosthetic joint infection

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.diagmicrobio.2015.03.002

Cite this

@article{de819265b0dc47ce9fde9ce2ab9345a2,

title = "Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection",

abstract = "Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC90/MIC50 were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.",

keywords = "Ceftriaxone, Oxacillin-susceptible Staphylococcus aureus, Prosthetic joint infection",

author = "Greenwood-Quaintance, {Kerryl E.} and Peggy Kohner and Osmon, {Douglas R.} and Abinash Virk and Robin Patel",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/j.diagmicrobio.2015.03.002",

language = "English (US)",

volume = "82",

pages = "177--178",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection

AU - Greenwood-Quaintance, Kerryl E.

AU - Kohner, Peggy

AU - Osmon, Douglas R.

AU - Virk, Abinash

AU - Patel, Robin

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC90/MIC50 were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.

AB - Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC90/MIC50 were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.

KW - Ceftriaxone

KW - Oxacillin-susceptible Staphylococcus aureus

KW - Prosthetic joint infection

UR - http://www.scopus.com/inward/record.url?scp=84929045353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929045353&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2015.03.002

DO - 10.1016/j.diagmicrobio.2015.03.002

M3 - Article

C2 - 25842182

AN - SCOPUS:84929045353

SN - 0732-8893

VL - 82

SP - 177

EP - 178

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 2

ER -

Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this